CIK 0001906324 · Large accelerated filer
QuidelOrtho Corp
Sign in to watch- Ticker
- QDEL
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Jan 1
- Entity type
- operating
- EIN
- 874496285
- Phone
- (858) 552-1100
- Business address
- 9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA, 92121
- Former names
- Coronado Topco, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-29 | Bowman Ronald Lee Chief Human Resources Officer | Option exercise · Restricted Stock Units | −2,938 | 5,878 | ||
| 2026-01-29 | Hodges Michelle A Chief Legal Officer | Grant or award | +7,836 | 40,432 | ||
| 2026-01-29 | Hodges Michelle A Chief Legal Officer | Shares withheld for taxes | −3,072 | $27.41 | $84K | 37,360 |
| 2026-01-29 | Hodges Michelle A Chief Legal Officer | Option exercise · Restricted Stock Units | −7,836 | 15,673 | ||
| 2026-01-29 | Blaser Brian J. President and CEO | Grant or award | +21,446 | 32,897 | ||
| 2026-01-29 | Blaser Brian J. President and CEO | Shares withheld for taxes | −7,755 | $27.41 | $213K | 25,142 |
| 2026-01-29 | Blaser Brian J. President and CEO | Option exercise · Restricted Stock Units | −21,446 | 42,892 | ||
| 2026-01-29 | Busky Joseph M. Chief Financial Officer | Grant or award | +8,425 | 39,852 | ||
| 2026-01-29 | Busky Joseph M. Chief Financial Officer | Shares withheld for taxes | −2,602 | $27.41 | $71K | 37,250 |
| 2026-01-29 | Busky Joseph M. Chief Financial Officer | Option exercise · Restricted Stock Units | −8,425 | 16,851 | ||
| 2025-12-10 | RHOADS ANN D Director | Purchase | +750 | $28.28 | $21K | 15,021 |
| 2025-11-26 | Wilkins Joseph D Jr. Director | Purchase | +370 | $27.96 | $10K | 11,876 |
| 2025-11-25 | WIDDER KENNETH J Director | Option exercise | +7,021 | $15.74 | $111K | 41,087 |
| 2025-11-25 | WIDDER KENNETH J Director | Sale | −4,026 | $27.81 | $112K | 37,061 |
| 2025-11-25 | WIDDER KENNETH J Director | Option exercise · Non-Qualified Stock Options | −7,021 | 0 | ||
| 2025-11-24 | Busky Joseph M. Chief Financial Officer | Purchase | +4,770 | $26.06 | $124K | 6,920 |
| 2025-11-21 | POLAN MARY LAKE PH D Director | Purchase | +1,000 | $22.43 | $22K | 12,640 |
| 2025-11-19 | Blaser Brian J. President and CEO | Purchase | +23,500 | $21.34 | $502K | 29,533 |
| 2025-11-18 | Hodges Michelle A Chief Legal Officer | Grant or award | +5,349 | 34,752 | ||
| 2025-11-18 | Hodges Michelle A Chief Legal Officer | Shares withheld for taxes | −2,717 | $21.28 | $58K | 32,035 |
Page 8 of 19 · 370 trades